Skip to main content
Tofflon Science and Technology Group Co.,Ltd. logo

Tofflon Science and Technology Group Co.,Ltd. — Investor Relations & Filings

Ticker · 300171 ISIN · CNE100000ZP0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,509 across all filing types
Latest filing 2022-08-03 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300171

About Tofflon Science and Technology Group Co.,Ltd.

https://www.tofflon.com

Tofflon Science and Technology Group Co.,Ltd. is a comprehensive service provider specializing in pharmaceutical equipment and integrated engineering solutions. The company focuses on the research, development, and manufacturing of advanced systems for the life science and pharmaceutical industries. Its core product portfolio includes lyophilization systems, aseptic filling lines, pharmaceutical water systems, and bioprocessing equipment. Tofflon provides end-to-end solutions ranging from laboratory-scale research tools to large-scale commercial production lines, incorporating automation and digitalization to support smart factory initiatives. Key offerings include freeze-dryers, isolator systems, and liquid processing equipment designed to meet global regulatory standards. By integrating process knowledge with engineering expertise, the group supports the production of vaccines, biologicals, and chemical drugs for a global client base.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于东富龙科技集团股份有限公司2022年度向特定对象发行A股股票之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行保荐书" (Issuance Sponsorship Letter) by CITIC Securities for Tofflon Science and Technology Group Co., Ltd. regarding a 2022 private placement of A shares on the ChiNext board. It contains detailed information about the securities issuance, including the sponsor institution, legal and regulatory compliance, financial data, shareholder structure, and the sponsor's due diligence and recommendation opinions. The document is a formal sponsorship letter required for securities issuance and listing approval, which is a regulatory filing related to capital raising and issuance activities. It is not an annual report, earnings release, or management report, nor is it a proxy statement or voting result announcement. It is a detailed regulatory filing document related to a capital/financing update, specifically the issuance of new shares to specific investors. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is the actual sponsorship letter, not just an announcement of a report, so it is not RPA or RNS. Confidence is high due to clear regulatory and issuance context.
2022-08-03 Chinese
发行注册环节反馈意见落实函
Regulatory Filings Classification · 95% confidence The document is a regulatory communication related to the registration and review process of a securities issuance by 东富龙科技集团股份有限公司. It references specific regulatory rules for securities issuance registration and includes feedback from the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange regarding the company's refinancing application. The document requests the company to respond to the feedback and disclose the response as a temporary announcement. It does not contain financial statements or detailed financial data but is rather a regulatory feedback and compliance communication. Given the nature of the document as a regulatory filing related to securities issuance registration and feedback, and the absence of financial report content, it fits best under Regulatory Filings (RNS).
2022-08-02 Chinese
关于收到《发行注册环节反馈意见落实函》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (655 characters) from a company regarding receipt of a regulatory feedback letter related to a stock issuance registration process. It references regulatory bodies such as the Shenzhen Stock Exchange and the China Securities Regulatory Commission, and discusses the company's obligation to respond to feedback and disclose updates. There is no financial data, no detailed report, and the document mainly informs about the regulatory process and next steps. It fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain a full report or financial statements.
2022-08-01 Chinese
2022年度向特定对象发行A股股票募集说明书（注册稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集说明书" (Prospectus) for a 2022 private placement of A shares by 东富龙科技集团股份有限公司 (Tofflon Science and Technology Group Co., Ltd). It contains detailed information about the issuance, including approval procedures, issuance objects, fundraising amount and usage, pricing, lock-up period, risk factors, and other disclosures typical of a securities offering prospectus. It is a comprehensive document describing a capital raising event through a private placement of shares to specific investors. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is not an annual report, earnings release, or regulatory filing, but a detailed offering prospectus for a share issuance. Therefore, the correct classification is CAP with high confidence.
2022-07-18 Chinese
中信证券股份有限公司关于东富龙科技集团股份有限公司2022年度向特定对象发行A股股票之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行保荐书" (Issuance Sponsorship Letter) by CITIC Securities for Tofflon Science and Technology Group Co., Ltd. regarding a 2022 private placement of A shares on the ChiNext board. It contains detailed information about the securities issuance, including the sponsor institution, legal and regulatory compliance, financial data, shareholder structure, and internal review procedures. The document is a formal sponsorship letter required for the issuance of new shares to specific investors, which is part of the capital raising process. It is not an earnings release, annual report, or management discussion, but rather a detailed capital/financing update related to a specific share issuance event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is the actual report, not just an announcement or certification.
2022-07-18 Chinese
中信证券股份有限公司关于东富龙科技集团股份有限公司2022年度向特定对象发行A股股票之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is a detailed listing sponsorship letter (上市保荐书) from CITIC Securities for Tofflon Science and Technology Group Co., Ltd. regarding a specific issuance of A shares in 2022. It includes extensive company background, business description, core technologies, financial data for recent years and quarters, risk factors, and regulatory compliance statements. The document is clearly related to a capital market transaction involving a share issuance and listing on the Shenzhen Stock Exchange. It is not a general annual report or earnings release but a formal sponsorship document for a securities issuance and listing. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length (15,000 characters) and content confirm it is the actual detailed report, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2022-07-18 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.